ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
27 Jun 2016 Press Release: EMA ESMO Workshop - Optimising the use of single arm trials in cancer drug development Anticancer agents & Biologic therapy
27 Jun 2016 ESMO Press Release: ESMO Launches First Leaders Generation Programme to Develop Oncology's Leaders of the Future
13 Jun 2016 ESMO 2016 Media Alert: From Disease Treatment to Patient Care
15 Apr 2016 ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours
14 Apr 2016 Press Statement: ESMO Welcomes Final Version of European Data Protection Regulation Bioethics, legal and economic issues
14 Apr 2016 ELCC 2016 Press Release: Immunotherapy With Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
14 Apr 2016 ELCC 2016 Press Release: Osimertinib Given as First-line Treatment May Alter Biology of EGFR-Mutated Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
11 Apr 2016 ELCC 2016 Press Release: Heine H. Hansen Award Goes to Suresh Senan
21 Mar 2016 Press Release: Back to the Essence of Medical Treatment in Oncology Bioethics, legal and economic issues
14 Mar 2016 Press Release: ESMO Appoints First Chief Medical Officer
04 Feb 2016 ESMO Press Release: World Cancer Day 2016 – ESMO and Patient Advocates, Together to Support Research Bioethics, legal and economic issues
02 Feb 2016 ESMO Press Release: Keith Hanson McGregor Appointed New ESMO CEO
19 Dec 2015 ESMO Asia 2015 Press Release: Afatinib a Better Choice for EGFR-Mutated Lung Cancer in First-Line Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 Dec 2015 ESMO Asia 2015 Press Release: More Patients with Lung Cancer Could Benefit from Immunotherapy, Study Shows Lung and other thoracic tumours - Cancer Immunology and Immunotherapy